Access Resources
2091 - 2100 of 7540 Results
Title
Year
-
RESTRICTEDTitle: North American survey on impact of the COVID-19 pandemic shutdown on DBS careJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 41End Page: 45Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011Best OA location URL: http://www.prd-journal.com/article/S1353802021003667/pdfCitation Count: 8
-
RESTRICTEDTitle: NRM 2021 Abstract BookletJournal Name: Journal of Cerebral Blood Flow & MetabolismPublisher: SAGE PublicationsVol: 41Issue #: 1_supplStart Page: 11End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/0271678x211061050Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/0271678X211061050Citation Count: 0
-
RESTRICTEDTitle: Structural basis of polyamine transport by human ATP13A2 (PARK9)Journal Name: Molecular CellPublisher: Elsevier BVVol: 81Issue #: 22Start Page: 4635End Page: 4649.e8Publication Date:Open Access(OA) Status: RESTRICTEDLicense: elsevier-specific: oa user license, elsevier-specific: oa user licenseDOI - Digital Object Identifier: 10.1016/j.molcel.2021.08.017Best OA location URL: http://www.cell.com/article/S1097276521006845/pdfCitation Count: 22
-
RESTRICTEDTitle: The commercial genetic testing landscape for Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 107End Page: 111Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.001Best OA location URL: http://www.prd-journal.com/article/S1353802021003564/pdfCitation Count: 15
- Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications2021RESTRICTEDTitle: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 59End Page: 66Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009Best OA location URL: http://www.prd-journal.com/article/S1353802021003643/pdfCitation Count: 24
-
RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 7
-
RESTRICTEDTitle: Wearable sensor-driven responsive deep brain stimulation for essential tremorJournal Name: Brain StimulationPublisher: Elsevier BVVol: 14Issue #: 6Start Page: 1434End Page: 1443Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.brs.2021.09.002Citation Count: 28
- White matter changes in drug-naïve Parkinson's disease patients with impulse control & probable REM sleep behavior disorders2021RESTRICTEDTitle: White matter changes in drug-naïve Parkinson's disease patients with impulse control & probable REM sleep behavior disordersJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 430Issue #:Start Page: 120032End Page: 120032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120032Citation Count: 3
-
RESTRICTEDTitle: Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta‐analysisJournal Name: ESC Heart FailurePublisher: WileyVol: 8Issue #: 6Start Page: 5466End Page: 5481Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ehf2.13648Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712892Citation Count: 13
- A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studies2021RESTRICTEDTitle: A systematic, concept‐based method of developing the exposure measure for drug safety and effectiveness studiesJournal Name: Pharmacoepidemiology and Drug SafetyPublisher: WileyVol: 31Issue #: 1Start Page: 13End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pds.5372Citation Count: 2